These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22705202)

  • 1. Anti-bacterial monoclonal antibodies: back to the future?
    Oleksiewicz MB; Nagy G; Nagy E
    Arch Biochem Biophys; 2012 Oct; 526(2):124-31. PubMed ID: 22705202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial monoclonal antibodies: the next generation?
    DiGiandomenico A; Sellman BR
    Curr Opin Microbiol; 2015 Oct; 27():78-85. PubMed ID: 26302478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-bacterial Monoclonal Antibodies.
    Nagy E; Nagy G; Power CA; Badarau A; Szijártó V
    Adv Exp Med Biol; 2017; 1053():119-153. PubMed ID: 29549638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines and antibiotic resistance.
    Mishra RP; Oviedo-Orta E; Prachi P; Rappuoli R; Bagnoli F
    Curr Opin Microbiol; 2012 Oct; 15(5):596-602. PubMed ID: 22981392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibiotic resistome: challenge and opportunity for therapeutic intervention.
    Martínez JL
    Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New screens and targets in antibacterial drug discovery.
    Falconer SB; Brown ED
    Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel heterodimer antibiotics: a review of recent patent literature.
    Long DD; Marquess DG
    Future Med Chem; 2009 Sep; 1(6):1037-50. PubMed ID: 21425993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative natural sources for a new generation of antibacterial agents.
    Taylor PW
    Int J Antimicrob Agents; 2013 Sep; 42(3):195-201. PubMed ID: 23796893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance.
    Colgan R; Powers JH
    Am Fam Physician; 2001 Sep; 64(6):999-1004. PubMed ID: 11578036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for new antibiotics: a molecule-centered perspective.
    Walsh CT; Wencewicz TA
    J Antibiot (Tokyo); 2014 Jan; 67(1):7-22. PubMed ID: 23756684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
    Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
    Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic use: present and future.
    Zinner SH
    New Microbiol; 2007 Jul; 30(3):321-5. PubMed ID: 17802919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into antibiotic resistance through metagenomic approaches.
    Schmieder R; Edwards R
    Future Microbiol; 2012 Jan; 7(1):73-89. PubMed ID: 22191448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-targeting by monotherapeutic antibacterials.
    Silver LL
    Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.